CC
EGRX

Centiva Capital’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Centiva Capital’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-7,698
Closed -$218K – 1612
2023
Q1 		$218K Buy
+7,698
New +$218K 0.01% 819